Kinaxis (OTCMKTS:KXSCF - Get Free Report) released its earnings results on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.14 by $997.86, reports. Kinaxis had a return on equity of 16.43% and a net margin of 12.90%.
Kinaxis Price Performance
Shares of KXSCF traded down $1.55 during trading hours on Wednesday, reaching $102.70. The stock had a trading volume of 9,736 shares, compared to its average volume of 10,753. Kinaxis has a 12 month low of $84.70 and a 12 month high of $158.91. The stock has a market capitalization of $2.81 billion and a PE ratio of 151.03. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.97 and a current ratio of 1.97. The company's 50-day moving average is $100.26 and its two-hundred day moving average is $111.74.
Analysts Set New Price Targets
Separately, Scotiabank reissued an "outperform" rating on shares of Kinaxis in a report on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of "Buy".
Get Our Latest Stock Report on KXSCF
About Kinaxis
(
Get Free Report)
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services. The company also provides strategic services, such as digital business transformation, advanced analytics, and digital innovation and acceleration services; implementation, including agile implementation methodology, RapidStart, sustainment, and rollout services; and continuous learning services consisting of Kinaxis learning center, custom learning programs, and certification, as well as support services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.